8-K: Align Technology Reports Q1 2025 Results, Clear Aligner Volume Up 6.2% Year-Over-Year

Align Technology announces its first quarter 2025 financial results, highlighting a 6.2% year-over-year increase in Clear Aligner volume and celebrating the 20 million Invisalign patient milestone.

Summary

• Align Technology reported Q1 2025 total revenues of $979.3 million, a decrease of 1.6% sequentially and 1.8% year-over-year.
• Clear Aligner volume increased by 6.2% year-over-year to 642.3 thousand cases, with teen and growing patient volume up 13.3%.
• Clear Aligner revenues were $796.8 million, down 2.5% year-over-year.
• Imaging Systems and CAD/CAM Services revenues increased 1.2% year-over-year to $182.4 million.
• The company's Q1 2025 operating income was $131.1 million, with an operating margin of 13.4%.
• Diluted net income per share was $1.27, while non-GAAP diluted net income per share was $2.13.
• Cash and cash equivalents totaled $873.0 million as of March 31, 2025, compared to $1,043.9 million at the end of Q4 2024.
• The company expects Q2 2025 worldwide revenues to be in the range of $1,050 million to $1,070 million.
• For fiscal year 2025, Align anticipates revenue growth in the range of 3.5% to 5.5%.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While revenue growth is not stellar, the company is meeting expectations, experiencing growth in key areas like clear aligner volume, and making strategic investments. The positive VAT ruling in the UK and the mitigation of tariff impacts further contribute to the positive outlook.

Positives

• Clear Aligner volume showed strong growth, particularly in the teen segment.
• The company achieved a significant milestone with 20 million Invisalign patients.
• Align received a favorable VAT ruling in the UK regarding Clear Aligner sales.
• The company expects sequential revenue growth in Q2 2025.
• Align is mitigating tariff exposure through supply chain adjustments.

Negatives

• Total revenues decreased by 1.8% year-over-year in Q1 2025.
• Clear Aligner revenues decreased by 2.5% year-over-year.
• Cash and cash equivalents decreased from $1,043.9 million to $873.0 million.
• Foreign exchange rates had an unfavorable impact on revenues and operating margin.

Risks

• Macroeconomic conditions, including inflation and currency exchange rate fluctuations, could impact the business.
• Tariffs and trade restrictions could affect product sales and costs.
• Competition from existing and new competitors poses a risk.
• The company faces risks related to the military conflicts in the Middle East and Ukraine, and tensions involving Taiwan and South China Sea and our operations and assets in Israel and Russia.
• The company's ability to protect its intellectual property rights is a risk factor.

Future Outlook

The company expects Q2 2025 worldwide revenues to be in the range of $1,050 million to $1,070 million and anticipates fiscal year 2025 revenue growth in the range of 3.5% to 5.5%.

Management Comments

• Align Technology President and CEO Joe Hogan stated that he is pleased to report first quarter revenues, operating margin, and earnings in line with our outlook.
• Joe Hogan noted that Fiscal 2025 is off to a good start with Q1 Clear Aligner volumes up both sequentially and year-over-year, reflecting strength in both the teens and adult patient segments, across all regions, driven by year-over-year strength across the Asia Pacific and EMEA regions, and growth in North America.

Industry Context

Align Technology's results reflect the ongoing adoption of clear aligner therapy and digital dentistry solutions. The company's focus on innovation, such as the iTero Lumina scanner and Align X-ray Insights, positions it to capitalize on the growing demand for advanced orthodontic and restorative treatments.

Comparison to Industry Standards

• While specific competitor data isn't provided, Align's growth in clear aligner volume suggests it is maintaining a strong position in the market compared to competitors like SmileDirectClub and traditional bracket-based orthodontics.
• The company's investment in digital solutions like iTero and exocad aligns with the industry trend towards digital workflows, similar to investments made by companies like Dentsply Sirona and Planmeca.

Stakeholder Impact

• Shareholders may be concerned about the slight revenue decline but encouraged by the growth in clear aligner volume and the company's outlook for future growth.
• Doctors using the Invisalign system will benefit from the continued innovation and expansion of the product line.
• Patients will benefit from increased access to Invisalign treatment and advancements in digital dentistry.

Next Steps

• The company will host a conference call on April 30, 2025, to review the Q1 2025 results and discuss future operating trends.
• Align will host an Investor Day on May 6, 2025.
• The company will continue to monitor the UK VAT situation and the US/Mexico tariff situation.

Key Dates

Keywords

Align Technology, Invisalign, Clear Aligners, iTero, Financial Results, Q1 2025, Revenue, Volume, Operating Margin, Net Income